Cite
HARVARD Citation
Ramasamy, M. et al. (2020). Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial. Lancet. 396 (10267), pp. 1979-1993. [Online].